Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Gerlach

Showing results (111-120 of 115) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 115 results.
British Journal of Pharmacology|January 5, 2001
Molecular impact of MinK on the enantiospecific block of I(Ks) by chromanolsC Lerche, G Seebohm, C I Wagner, et al.
Journal of Medicinal Chemistry|November 2, 2001
Synthesis and activity of novel and selective I(Ks)-channel blockersU Gerlach, J Brendel, H J Lang, et al.
Hepato-Gastroenterology|February 10, 1999
Phase II clinical trial of combined natural interferon-beta plus recombinant interferon-gamma treatment of chronic hepatitis BE Musch, B Högemann, A Gerritzen, et al.
Circulation|November 26, 1999
Rate- and site-dependent effects of propafenone, dofetilide, and the new I(Ks)-blocking agent chromanol 293b on individual muscle layers of the intact canine heartA Bauer, R Becker, K D Freigang, et al.
Deutsche Medizinische Wochenschrift (1946)|August 1, 1971
[Exchange transfusions in acute liver failure]G Baltzer, W Dölle, U Bär, et al.
Pageof 12

Showing results (111-120 of 115) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 115 results.
British Journal of Pharmacology|January 5, 2001
Molecular impact of MinK on the enantiospecific block of I(Ks) by chromanolsC Lerche, G Seebohm, C I Wagner, et al.
Journal of Medicinal Chemistry|November 2, 2001
Synthesis and activity of novel and selective I(Ks)-channel blockersU Gerlach, J Brendel, H J Lang, et al.
Hepato-Gastroenterology|February 10, 1999
Phase II clinical trial of combined natural interferon-beta plus recombinant interferon-gamma treatment of chronic hepatitis BE Musch, B Högemann, A Gerritzen, et al.
Circulation|November 26, 1999
Rate- and site-dependent effects of propafenone, dofetilide, and the new I(Ks)-blocking agent chromanol 293b on individual muscle layers of the intact canine heartA Bauer, R Becker, K D Freigang, et al.
Deutsche Medizinische Wochenschrift (1946)|August 1, 1971
[Exchange transfusions in acute liver failure]G Baltzer, W Dölle, U Bär, et al.
Pageof 12